TRIAZOLE-SUBSTITUTED IMIDAZO[1,2-A]PYRIMIDINES AS CGAS INHIBITORS

The present invention relates to compounds, compositions containing them, and to their use in the treatment of various disorders, in particular autoimmune, autoinflammatory or immune-mediated conditions, such as systemic lupus erythematosus (SLE), cutaneous lupus erythematosus (CLE) and lupus nephri...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: REIF, Alexander, BOTYANSZKI, Janos, ZHANG, Daohua, RAMANJULU, Joshi, WIGGALL, Kenneth, CHARNLEY, Adam, KING, Bryan, NEWLANDER, Kenneth, DONG, Xiaoyang, HUMPHREYS, Philip, MARCUS, Kimberly, PERO, Joseph, RAHMAN, Attiq
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to compounds, compositions containing them, and to their use in the treatment of various disorders, in particular autoimmune, autoinflammatory or immune-mediated conditions, such as systemic lupus erythematosus (SLE), cutaneous lupus erythematosus (CLE) and lupus nephritis. La présente invention concerne des composés, des compositions les contenant, et leur utilisation dans le traitement de divers troubles, en particulier d'affections auto-immunes, auto-inflammatoires ou à médiation immunitaire, telles que le lupus érythémateux disséminé (LED), le lupus érythémateux cutané (LEC) et la néphropathie lupique.